Click HereTherapeutic Options not on the QTdrugs List
Attention All Commercial Users of QTdrugs Technology
Commercial use or reproduction of the QTdrugs list or other copyrighted content from the CredibleMeds® website is prohibited unless licensed or authorized by AZCERT, Inc. Commercial use by a company's employee(s) or contractor(s) is defined in AZCERT's Terms of Use.
AZCERT's policy defines permissable, non-commercial use as any use by employees of government agencies, academic institutions, not-for-profit entities or self-employed healthcare providers.
Online orders for licenses can be placed here and quotes for licensing fees are available by contacting info@azcert.org.
In the early days of the COVID-19 pandemic, several drugs already on the market were widely touted as potentially effective and were often prescribed in the hope that they could alter the course of COVID-19. Many of those drugs were originally…
Merriam-Webster defines contraindicated as “not advised as a course of treatment or procedure” but the definition fails to address who or what type of organization/agency should have the authority to decide if a treatment is contraindicated under…
A century ago, Drs. Bazett and Fridericia separately and simultaneously published their recommendations for how to correct the QT interval for differences in heart rate. Bazett recommended dividing the QT by the square root of the heart rate…
Health screening is an established component of high-quality medical care and doctors regularly screen their patients for disease risk markers such as high cholesterol or hypertension. Yet, little progress has been made in finding ways to prevent…
Prolongation of the QT interval is a well-established risk factor that predicts increased mortality from sudden cardiac death.1 Identification of patients with the highest risk of QT prolongation and associated adverse outcomes has been facilitated…
Because the safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs, we are informing you of these changes to the QTdrugs.org lists:
1. Add Ribociclib and Necitumumab to Possible Risk List
2.…
Following the successful launch of the app, Cardiology Today recently published an article in their newest edition featuring the new mobile offering for patients and healthcare providers, written by Dr. Ray Woosley, Founder of CredibleMeds.
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW, Gallo T, Woosley RD, Lambson J. and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.
Print
Share
RSS
Donate
